Fig. 3From: Intensive cycles of neoadjuvant camrelizumab combined with chemotherapy in locally advanced esophageal squamous cell carcinoma: a single-arm, phase II trialSurvival of the patients who received surgery. A Overall survival. B Disease-free survivalBack to article page